Los Angeles Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Los Angeles Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156K	Sell	64,398 -427,443	-87%	-$1.04M	﹤0.01%	1231
2026 Q1	$1.17M	Buy	491,841 +363,965	+285%	+$1.26M	﹤0.01%	637
2025 Q4	$541K	Sell	127,876 -20,576	-14%	-$99.7K	﹤0.01%	858
2025 Q3	$626K	Sell	148,452 -131,470	-47%	-$611K	﹤0.01%	848
2025 Q2	$1.02M	Sell	279,922 -56,048	-17%	-$209K	﹤0.01%	632
2025 Q1	$1.45M	Buy	335,970 +11,959	+4%	+$48.3K	0.01%	464
2024 Q4	$1.04M	Sell	324,011 -6,280	-2%	-$21.1K	﹤0.01%	607
2024 Q3	$945K	Sell	330,291 -38,300	-10%	-$107K	﹤0.01%	666
2024 Q2	$1.03M	Sell	368,591 -131,976	-26%	-$354K	﹤0.01%	643
2024 Q1	$1.42M	Buy	500,567 +157,575	+46%	+$536K	﹤0.01%	580
2023 Q4	$1.4M	Sell	342,992 -53,030	-13%	-$149K	0.01%	561
2023 Q3	$1.26M	Sell	396,022 -145,952	-27%	-$464K	0.01%	564
2023 Q2	$1.8M	Buy	541,974 +38,651	+8%	+$114K	0.01%	518
2023 Q1	$1.07M	Buy	503,323 +117,075	+30%	+$289K	﹤0.01%	647
2022 Q4	$1.04M	Sell	386,248 -52,655	-12%	-$154K	0.01%	696
2022 Q3	$1.42M	Sell	438,903 -7,206	-2%	-$32.6K	0.01%	591
2022 Q2	$2.18M	Buy	446,109 +314,414	+239%	+$1.94M	0.01%	516
2022 Q1	$1M	Buy	131,695 +64,124	+95%	+$496K	﹤0.01%	759
2021 Q4	$624K	Buy	+67,571	New	+$718K	﹤0.01%	901

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Los Angeles Capital Management's ORGO Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Organogenesis Holdings (ORGO) stake by 87% in Q2 2026, selling an estimated $1.04M and leaving 64,398 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Los Angeles Capital Management first reported a position in ORGO in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.18M in Q2 2022. 135 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Los Angeles Capital Management held 64,398 shares of Organogenesis Holdings worth $156K as of Q2 2026.
Los Angeles Capital Management sold 427,443 Organogenesis Holdings shares in Q2 2026, an estimated $1.04M.
Organogenesis Holdings made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1231 holding.
Los Angeles Capital Management first reported a position in Organogenesis Holdings in Q4 2021 and has held it in 19 quarters since.
Los Angeles Capital Management's Organogenesis Holdings position peaked at $2.18M in Q2 2022.
135 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.